Improving clinical trial outcomes in amyotrophic lateral sclerosis

Individuals who are diagnosed with amyotrophic lateral sclerosis (ALS) today face the same historically intransigent problem that has existed since the initial description of the disease in the 1860s — a lack of effective therapies. In part, the development of new treatments has been hampered by an...

詳細記述

保存先:
書誌詳細
出版年:Nat Rev Neurol
主要な著者: Kiernan, Matthew C., Vucic, Steve, Talbot, Kevin, McDermott, Christopher J., Hardiman, Orla, Shefner, Jeremy M., Al-Chalabi, Ammar, Huynh, William, Cudkowicz, Merit, Talman, Paul, Van den Berg, Leonard H., Dharmadasa, Thanuja, Wicks, Paul, Reilly, Claire, Turner, Martin R.
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2020
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747476/
https://ncbi.nlm.nih.gov/pubmed/33340024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41582-020-00434-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料